No Longer Available EXPANDED_ACCESS NCT03501940

F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer

18F-DCFPyL PET/CT in the Evaluation of Patients With Biochemical Recurrence of Prostate Cancer and Non-Contributory CT Scans

Sponsor: Andrei Iagaru

Conditions PSA Level Greater Than 0.2 PSA Level Greater Than or Equal to Two PSA Progression Prostate Adenocarcinoma Recurrent Prostate Carcinoma

Interventions Computed Tomography Fluorine F 18 DCFPyL Laboratory Biomarker Analysis Positron Emission Tomography

Updated 10 times since 2018 Last updated: Jan 6, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on PSA Level Greater Than 0.2 and PSA Level Greater Than or Equal to Two, this trial is ongoing. The trial is conducted by Andrei Iagaru and has accumulated 10 data snapshots since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

No Longer Available
Jul 2024 — Sep 2024 [monthly]

No Longer Available
Feb 2022 — Jul 2024 [monthly]

No Longer Available

Status: Available → No Longer Available
Feb 2021 — Feb 2022 [monthly]

Available
Jan 2021 — Feb 2021 [monthly]

Available

▶ Show 5 earlier versions

Sep 2020 — Jan 2021 [monthly]

Available
Aug 2019 — Sep 2020 [monthly]

Available
Jul 2018 — Aug 2019 [monthly]

Available
Jun 2018 — Jul 2018 [monthly]

Available
May 2018 — Jun 2018 [monthly]

Available

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Andrei Iagaru

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Palo Alto, United States